The oncometabolite 5 '-methylthioadenosine (MTA) blocks NK cell functions early after activation

Jacobs B, Schlögl S, Mougiakakos D, Mackensen A, Aigner M, Völkl S (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 274-275

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Benedikt Jacobs Department of Medicine 5 – Haematology and Oncology Sebastian Schlögl Lehrstuhl für Innere Medizin V Dimitrios Mougiakakos Professur für Hämatologie/Onkologie mit dem Schwerpunkt Tumorimmunologie Andreas Mackensen Lehrstuhl für Innere Medizin V Simon Völkl Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Jacobs, B., Schlögl, S., Mougiakakos, D., Mackensen, A., Aigner, M., & Völkl, S. (2019). The oncometabolite 5 '-methylthioadenosine (MTA) blocks NK cell functions early after activation. In ONCOLOGY RESEARCH AND TREATMENT (pp. 274-275). BASEL: KARGER.

MLA:

Jacobs, Benedikt, et al. "The oncometabolite 5 '-methylthioadenosine (MTA) blocks NK cell functions early after activation." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2019. 274-275.

BibTeX: Download